Miguel Salavert
About
In The Last Decade
Miguel Salavert
188 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 115
- Epidemiology 1.7k
- Infectious Diseases 1.6k
- Surgery 489
- Oncology 318
- Hematology 278
Countries citing papers authored by Miguel Salavert
This map shows the geographic impact of Miguel Salavert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Salavert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Salavert more than expected).
Fields of papers citing papers by Miguel Salavert
This network shows the impact of papers produced by Miguel Salavert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Salavert. The network helps show where Miguel Salavert may publish in the future.
Co-authorship network of co-authors of Miguel Salavert
This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Salavert. A scholar is included among the top collaborators of Miguel Salavert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Salavert. Miguel Salavert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 8 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | Fosfomicina en las infecciones producidas por gramnegativos multirresistentes | 3 |
| 9 | 26 | |
| 10 | 2 | |
| 11 | Tratamiento no antibiótico de las enfermedades infecciosas | 2 |
| 12 | Análisis de los factores de riesgo clave para infecciones fúngicas invasoras en pacientes onco-hematológicos: estudio Delphi | 4 |
| 13 | 20 | |
| 14 | Recomendaciones en el tratamiento antibiótico empírico de la infección intraabdominal | 17 |
| 15 | Daptomicina: revitalizando un antiguo fármaco ante la necesidad de nuevos agentes activos frente a bacterias grampositivas multirresistentes | 2 |
| 16 | La tigeciclina, el primer antibiótico de una nueva clase: las glicilciclinas | 2 |
| 17 | Bacteriemia por estreptococos del grupo A: resultados y factores pronóstico. | 9 |
| 18 | Efecto de los nuevos antifúngicos en la etiología de las micosis invasoras: emergencia, resistencia e infección de brecha | 1 |
| 19 | Complicaciones infecciosas del tratamiento con agentes biológicos | 1 |
| 20 | Guía del Hospital Universitario La Fe para la profilaxis y el tratamiento de las infecciones fúngicas en los enfermos inmunodeprimidos o que requieren cuidados especiales | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.